domingo, 13 de noviembre de 2016

Improving the Lives of People with Sickle Cell Disease ► Tuesday, November 15, 2016, at 1 pm EST

Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Improving the Lives of People with Sickle Cell Disease | Public Health Grand Rounds | CDC

Improving the Lives of People with Sickle Cell Disease

Tuesday, November 15, 2016, at 1 pm EST
 a little girl with a doctor

Sickle cell disease (SCD) describes a group of inherited disorders that can cause red blood cells to develop in an abnormal rigid sickle or crescent shape. These inflexible sickle-shaped cells can stick to the walls of blood vessels and block the flow of blood completely, leading to a lack of oxygen in surrounding tissues. In addition to sudden, excruciating pain events known as pain crises, SCD can lead to strokes, organ damage, joint and bone problems, and other severe health consequences. The effects of SCD begin around 5 or 6 months of age and continue over a person's lifetime. There is no national registry for SCD, but experts estimate that this disease affects approximately 100,000 people in the United States alone.
Over the past 30 years, treatments for SCD and its complications have improved average life expectancy, but these treatments can be costly and invasive. Additionally, healthcare needs and access to care may change over the course of a patient's life. Through continued collaboration with clinicians, researchers and the SCD community, we can identify critical gaps and better understand how these treatments can improve the lives of people with SCD.
This session of Public Health Grand Rounds discusses SCD, what we know, and how far we have come in just a few decades.

Presented By:

Mary Hulihan, DrPHHealth Scientist, Epidemiology and Surveillance Branch
Division of Blood Disorders
National Center on Birth Defects and Developmental Disabilities, CDC
"Using Data to Understand Gaps in Care and Outcomes"
Kim Smith-Whitley, MD
Medical Director, Sickle Cell Clinical Program
Children's Hospital of Philadelphia
Chief Medical Officer (Immediate Past)
Sickle Cell Association of America
"The Sickle Cell Community and Pediatric Care"
Kathryn Hassell, MDProfessor of Medicine, Division of Hematology
University of Colorado Denver
"Improving Outcomes for Adults with Sickle Cell Disease"
Jean Raphael, MD, MPHAssociate Professor, Pediatrics
Baylor College of Medicine
Director, Center for Child Health Policy and Advocacy
Texas Children's Hospital
"A Health Policy Approach to Sickle Cell Disease"

Facilitated By:

John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds
Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds

Continuing Education

Grand Rounds is available for Continuing Education. Click here for more information.
Public Health Genomics Knowledge Base (v1.2)
Genomics & Health Impact Update banner with DNA in background

Last Posted: Nov-10-2016 11AM

Improving the Lives of People with Sickle Cell Disease
CDC Public Health Grand Rounds, November 15, 1-2 pm Brand
Pediatric Sickle Cell Disease - Past Successes and Future Challenges.
Meier Emily Riehm et al. Pediatric research 2016 Oct
Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.
Geard Amy et al. Omics : a journal of integrative biology 2016 Oct (10) 581-592

More information on this topic


Last Updated: Nov 08, 2016
CDC Resources with and image of DNA
Seletced Insights & Reviews with various images of researchers in labortory environments
Epidemiology with an image of a crowd of people with a double helix
Translational Research with two images of people talking to a genetic counselor and an image of a hand with wrapped sequecing around it
Evidence Synthesis with an image of sequencing and a double helix
Practice & Implementation with images of people taking to a doctor and a nurse examining a child

Relevant Resources

No hay comentarios:

Publicar un comentario